Free Trial

Inogen (INGN) News Today

Inogen logo
$9.40 -0.06 (-0.63%)
(As of 10:15 AM ET)
Inogen, Inc. stock logo
Brown Capital Management LLC Lowers Position in Inogen, Inc. (NASDAQ:INGN)
Brown Capital Management LLC reduced its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 20.1% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,558,458 shares of the medical technology company's stock after selling 392,478 shares during the per
Inogen, Inc. stock logo
Short Interest in Inogen, Inc. (NASDAQ:INGN) Declines By 11.4%
Inogen, Inc. (NASDAQ:INGN - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 826,300 shares, a decline of 11.4% from the October 15th total of 932,600 shares. Based on an average daily volume of 190,100 shares, the days-to-cover ratio is currently 4.3 days.
Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript
Inogen, Inc. Reports Third Quarter 2024 Financial Results
Needham Keeps Their Hold Rating on Inogen (INGN)
Inogen, Inc. (INGN): A Bear Case Theory
Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Earns "Hold" Rating from Needham & Company LLC
Needham & Company LLC restated a "hold" rating on shares of Inogen in a research report on Friday.
Inogen to Present at Upcoming Investor Conferences
Inogen, Inc. stock logo
Inogen (INGN) Set to Announce Quarterly Earnings on Thursday
Inogen (NASDAQ:INGN) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636745)
Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Stock Passes Below 200 Day Moving Average - Here's Why
Inogen (NASDAQ:INGN) Stock Price Passes Below 200 Day Moving Average - Should You Sell?
Inogen, Inc. stock logo
Sanctuary Advisors LLC Acquires Shares of 80,075 Inogen, Inc. (NASDAQ:INGN)
Sanctuary Advisors LLC bought a new position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 80,075 shares of the medical technology
Inogen, Inc. stock logo
Marshall Wace LLP Cuts Stock Holdings in Inogen, Inc. (NASDAQ:INGN)
Marshall Wace LLP decreased its position in Inogen, Inc. (NASDAQ:INGN - Free Report) by 62.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 125,205 shares of the medical technology company's stock after sel
Inogen, Inc. stock logo
B. Riley Wealth Advisors Inc. Buys Shares of 56,200 Inogen, Inc. (NASDAQ:INGN)
B. Riley Wealth Advisors Inc. bought a new position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 56,200 shares of the medical technology company'
Inogen, Inc. stock logo
AQR Capital Management LLC Raises Stock Holdings in Inogen, Inc. (NASDAQ:INGN)
AQR Capital Management LLC boosted its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 29.3% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 570,994 shares of the medical technology company's stock after buyi
Inogen: Upside Seems Limited After Big Move Up
Inogen, Inc. stock logo
Inogen, Inc. (NASDAQ:INGN) Position Increased by Divisadero Street Capital Management LP
Divisadero Street Capital Management LP increased its holdings in Inogen, Inc. (NASDAQ:INGN - Free Report) by 682.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,346,766 shares of the medical technology company's st
Inogen, Inc. stock logo
Monaco Asset Management SAM Purchases New Holdings in Inogen, Inc. (NASDAQ:INGN)
Monaco Asset Management SAM purchased a new stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 75,000 shares of the medical technology company's stock, valued at
Inogen, Inc. stock logo
Inogen, Inc. (NASDAQ:INGN) Sees Large Decline in Short Interest
Inogen, Inc. (NASDAQ:INGN - Get Free Report) saw a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 1,350,000 shares, a decline of 8.2% from the July 15th total of 1,470,000 shares. Based on an average daily trading volume, of 224,000 shares, the short-interest ratio is presently 6.0 days.
Inogen, Inc. stock logo
Vanguard Group Inc. Increases Position in Inogen, Inc. (NASDAQ:INGN)
Vanguard Group Inc. boosted its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 4.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,424,026 shares of the medi
Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Upgraded to Hold at StockNews.com
StockNews.com raised Inogen from a "sell" rating to a "hold" rating in a research note on Tuesday.
Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Issues Earnings Results, Beats Expectations By $0.31 EPS
Inogen (NASDAQ:INGN - Get Free Report) announced its earnings results on Tuesday. The medical technology company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.55) by $0.31. Inogen had a negative return on equity of 42.87% and a negative net margin of 30.07%. The company had revenue of $88.77 million for the quarter, compared to analyst estimates of $82.50 million. During the same quarter last year, the company earned ($0.42) earnings per share. The firm's quarterly revenue was up 6.1% compared to the same quarter last year.
Inogen, Inc. stock logo
Inogen's (INGN) Hold Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reaffirmed a "hold" rating on shares of Inogen in a report on Wednesday.
Inogen Announces Second Quarter 2024 Financial Results
Inogen, Inc. stock logo
StockNews.com Downgrades Inogen (NASDAQ:INGN) to Sell
StockNews.com lowered shares of Inogen from a "hold" rating to a "sell" rating in a research report on Monday.
Inogen, Inc. stock logo
Jacobs Levy Equity Management Inc. Has $3.01 Million Stake in Inogen, Inc. (NASDAQ:INGN)
Jacobs Levy Equity Management Inc. cut its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 19.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 372,338 shares of the medical technology company's stock after
Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Inogen from a "sell" rating to a "hold" rating in a research report on Saturday.
Inogen, Inc. stock logo
Inogen (NASDAQ:INGN) Cut to Sell at StockNews.com
StockNews.com lowered shares of Inogen from a "hold" rating to a "sell" rating in a research report on Friday.
Inogen, Inc. stock logo
Brown Capital Management LLC Has $8.57 Million Holdings in Inogen, Inc. (NASDAQ:INGN)
Brown Capital Management LLC lessened its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 29.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,560,409 shares of the medical technology com
Inogen, Inc. stock logo
Jason Somer Sells 10,000 Shares of Inogen, Inc. (NASDAQ:INGN) Stock
Inogen, Inc. (NASDAQ:INGN - Get Free Report) EVP Jason Somer sold 10,000 shares of the company's stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $8.56, for a total transaction of $85,600.00. Following the transaction, the executive vice president now owns 4,452 shares in the company, valued at approximately $38,109.12. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Stifel Nicolaus Reaffirms Their Hold Rating on Inogen (INGN)
Get Inogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

INGN Media Mentions By Week

INGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INGN
News Sentiment

0.63

0.46

Average
Medical
News Sentiment

INGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INGN Articles
This Week

2

2

INGN Articles
Average Week

Get Inogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:INGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners